PTLA - Portola Pharmaceuticals Q4 2019 Earnings Preview

February, 25 2020 05:35 PM Portola Pharmaceuticals Inc.

Portola Pharmaceuticals (NASDAQ:PTLA) is scheduled to announce Q4 earnings results on Wednesday, February 26th, after market close.
The consensus EPS Estimate is -$0.78 (+25.0% Y/Y) and the consensus Revenue Estimate is $29.24M (+91.1% Y/Y).
Over the last 2 years, PTLA has beaten EPS estimates 88% of the time and has beaten revenue estimates 75% of the time.
Over the last 3 months, EPS estimates have seen 0 upward revisions and 3 downward. Revenue estimates have seen 0 upward revisions and 5 downward.
More news on: Portola Pharmaceuticals, Inc., Earnings news and commentary, , Healthcare stocks news,

Company Name:	Portola Pharmaceuticals Inc.
Stock Symbol:	PTLA
Market:	NASDAQ
Website:	portola.com